Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000897069-03-000382
Filing Date
2003-03-31
Accepted
2003-03-31 14:31:48
Documents
1
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K irm244.txt 6-K 158545
  Complete submission text file 0000897069-03-000382.txt   160071
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 514-332-32
NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-12033 | Film No.: 03629300
SIC: 2835 In Vitro & In Vivo Diagnostic Substances